Avandia (Rosiglitazone Maleate) is a Type 2 diabetes medication manufactured by GlaxoSmithKline used to control blood sugar levels. It has been marketed since 1999, and was a blockbuster hit in the market, generating over $2 billion in annual revenue by 2006. The sales dramatically downgraded when possible Avandia adverse effects, including cardiovascular problems, came to the public’s attention. The number of people who are affected by Avandia’s side effects is rising, and so are the lawsuits filed against its manufacturer.
Consumers are warned that Avandia must not be taken for patients who are undergoing insulin treatment. Despite of the Avandia’s revenue downfall, it still is one of the bestselling prescription diabetes medicines in the United States. A study by the FDA in 2006, involving 227,571 patients concluded frightening results; 27% of the patient developed stroke, 25% are likely to develop heart problems and 14% are likely to die. According to a numerous clinical studies, Avandia is linked to as many as 100,000 heart attack cases.
GlaxoSmithKline has been facing $6 billion in liability litigation costs as countless of patients filed lawsuits and more are expected to step forward and file complaints. If you suffer from heart problems after taking GlaxoSmithKline’s Avandia, you should contact a lawyer to find out about your legal options. A case against the manufacturer can be filed and you might be awarded with compensation for the damages you suffered from taking this drug.